New Serum Test for Mad Cow Disease

Since the test detects the disease in live cattle, there is no need to kill the cows to be tested. The cooperative work of the two developers focused on identifying the molecular basis of the disease and methods for detecting affected cattle. Chronix contributed its expertise in nucleic acid detection and expression profiling to the test's development. The company plans to focus additional research efforts on understanding the relationship between BSE and new variant Creutzfeldt-Jakob (nvCFJ) disease in humans, which appears to be closely related.

"I am confident important diagnostic technologies will emerge from this collaboration that can be useful in ensuring the safety of the food supply,” said Bertram Brenig, director of the Institute of Veterinary Medicine.




Related Links:
Chronix